PHARMAPLEX: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMAPLEX
Largest movements
- Cash -€102,833
down €102,833 (-40.0%), from €257,068 to €154,235
mainly Current investments (-€90,908) and Other debts (-€37,492)
- Current investments +€90,908
new in 2025: €90,908
- Receivables within one year -€9,867
down €9,867 (-4.0%), from €246,607 to €236,740
of which Trade receivables: -€11,145
- Other debts -€37,492
down €37,492 (-14.4%), from €260,136 to €222,644
- Reserves +€23,269
up €23,269 (+13.8%), from €168,340 to €191,609
- Gross operating margin -€8,275
down €8,275 (-18.1%), from €45,650 to €37,375
- Financial income -€6,773
down €6,773 (-73.3%), from €9,246 to €2,473
- Taxes -€5,563
down €5,563 (-30.6%), from €18,191 to €12,628
- Financial charges +€1,285
up €1,285 (+197%), from €654 to €1,939
- Depreciation -€633
no longer reported in 2025 (was €633)
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €505,739 | €482,967 | -€22,772 | -4.5% |
| Current assets | 29/58 | €505,739 | €482,967 | -€22,772 | -4.5% |
| Amounts receivable within one year | 40/41 | €246,607 | €236,740 | -€9,867 | -4.0% |
| Trade receivables | 40 | €246,075 | €234,929 | -€11,145 | -4.5% |
| Other amounts receivable | 41 | €533 | €1,811 | +€1,279 | +240% |
| Current investments | 50/53 | - | €90,908 | +€90,908 | |
| Cash at bank and in hand | 54/58 | €257,068 | €154,235 | -€102,833 | -40.0% |
| Deferred charges and accrued income | 490/1 | €2,063 | €1,083 | -€980 | -47.5% |
| Total equity and liabilities | 10/49 | €505,739 | €482,967 | -€22,772 | -4.5% |
| Equity | 10/15 | €180,831 | €204,100 | +€23,269 | +12.9% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €168,340 | €191,609 | +€23,269 | +13.8% |
| Non-distributable reserves | 130/1 | €168,340 | €191,609 | +€23,269 | +13.8% |
| Other | 1319 | €168,340 | €191,609 | +€23,269 | +13.8% |
| Profit (loss) carried forward | 14 | €91 | €91 | +€0 | +0.2% |
| Amounts payable | 17/49 | €324,909 | €278,867 | -€46,042 | -14.2% |
| Amounts payable within one year | 42/48 | €323,133 | €276,635 | -€46,497 | -14.4% |
| Trade debts | 44 | €54,262 | €49,257 | -€5,005 | -9.2% |
| Suppliers | 440/4 | €54,262 | €49,257 | -€5,005 | -9.2% |
| Taxes, remuneration and social security | 45 | €8,735 | €4,734 | -€4,000 | -45.8% |
| Taxes | 450/3 | €8,735 | €4,734 | -€4,000 | -45.8% |
| Other amounts payable | 47/48 | €260,136 | €222,644 | -€37,492 | -14.4% |
| Accrued charges and deferred income | 492/3 | €1,776 | €2,232 | +€456 | +25.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €633 | - | -€633 | |
| Other operating charges | 640/8 | €2,034 | €2,012 | -€22 | -1.1% |
| Gross operating margin | 9900 | €45,650 | €37,375 | -€8,275 | -18.1% |
| Operating profit (loss) | 9901 | €42,983 | €35,363 | -€7,620 | -17.7% |
| Financial income | 75/76B | €9,246 | €2,473 | -€6,773 | -73.3% |
| Recurring financial income | 75 | €9,246 | €2,473 | -€6,773 | -73.3% |
| Financial charges | 65/66B | €654 | €1,939 | +€1,285 | +197% |
| Recurring financial charges | 65 | €654 | €1,939 | +€1,285 | +197% |
| Profit (loss) for the period before taxes | 9903 | €51,576 | €35,898 | -€15,678 | -30.4% |
| Income taxes | 67/77 | €18,191 | €12,628 | -€5,563 | -30.6% |
| Profit (loss) for the period | 9904 | €33,385 | €23,269 | -€10,115 | -30.3% |
| Profit (loss) for the period to be appropriated | 9905 | €33,385 | €23,269 | -€10,115 | -30.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.